These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 31114833)

  • 1. Microfluidic droplet liquid reactors for active pharmaceutical ingredient crystallization by diffusion controlled solvent extraction.
    Tona RM; McDonald TAO; Akhavein N; Larkin JD; Lai D
    Lab Chip; 2019 Jun; 19(12):2127-2137. PubMed ID: 31114833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seeded droplet microfluidic system for small molecule crystallization.
    Garg N; Tona R; Martin P; Martin-Soladana PM; Ward G; Douillet N; Lai D
    Lab Chip; 2020 May; 20(10):1815-1826. PubMed ID: 32322845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high-throughput system combining microfluidic hydrogel droplets with deep learning for screening the antisolvent-crystallization conditions of active pharmaceutical ingredients.
    Su Z; He J; Zhou P; Huang L; Zhou J
    Lab Chip; 2020 Jun; 20(11):1907-1916. PubMed ID: 32420560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal Habits of Itraconazole Microcrystals: Unusual Isomorphic Intergrowths Induced via Tuning Recrystallization Conditions.
    Mugheirbi NA; Tajber L
    Mol Pharm; 2015 Sep; 12(9):3468-78. PubMed ID: 26275018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Droplet-Templated Antisolvent Spherical Crystallization of Hydrophilic and Hydrophobic Drugs with an in situ Formed Binder.
    Gu T; Yeap EWQ; Cao Z; Ng DZL; Ren Y; Chen R; Khan SA; Hatton TA
    Adv Healthc Mater; 2018 Feb; 7(3):. PubMed ID: 28961377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development in modeling submicron particle formation in two phases flow of solvent-supercritical antisolvent emulsion.
    Dukhin SS; Shen Y; Dave R; Pfeffer R
    Adv Colloid Interface Sci; 2007 Oct; 134-135():72-88. PubMed ID: 17568550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Habit Modification of the Active Pharmaceutical Ingredient Lovastatin Through a Predictive Solvent Selection Approach.
    Turner TD; Hatcher LE; Wilson CC; Roberts KJ
    J Pharm Sci; 2019 May; 108(5):1779-1787. PubMed ID: 30590015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The construction, prediction and measurement of co-crystal ternary phase diagrams as a tool for solvent selection.
    Holaň J; Stěpánek F; Billot P; Ridvan L
    Eur J Pharm Sci; 2014 Oct; 63():124-31. PubMed ID: 24995701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogel Microparticle-Templated Anti-Solvent Crystallization of Small-Molecule Drugs.
    Bora M; Hsu MN; Khan SA; Doyle PS
    Adv Healthc Mater; 2022 Apr; 11(8):e2102252. PubMed ID: 34936230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging role of primary heterogeneous nucleation in pharmaceutical crystallization.
    Thakore SD; Sood A; Bansal AK
    Drug Dev Res; 2020 Feb; 81(1):3-22. PubMed ID: 31800139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of feedback control and in situ milling to improve particle size and shape in the crystallization of a slow growing needle-like active pharmaceutical ingredient.
    Yang Y; Pal K; Koswara A; Sun Q; Zhang Y; Quon J; McKeown R; Goss C; Nagy ZK
    Int J Pharm; 2017 Nov; 533(1):49-61. PubMed ID: 28935256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Solvent Selection on Crystal Habit of 5-Aminosalicylic Acid-Combined Experimental and Computational Approach.
    Pudasaini N; Parker CR; Hagen SU; Bond AD; Rantanen J
    J Pharm Sci; 2018 Apr; 107(4):1112-1121. PubMed ID: 29247740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microfluidic approach to the formation of internally porous polymer particles by solvent extraction.
    Watanabe T; G Lopez C; Douglas JF; Ono T; Cabral JT
    Langmuir; 2014 Mar; 30(9):2470-9. PubMed ID: 24568261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisolvent membrane crystallization of pharmaceutical compounds.
    Di Profio G; Stabile C; Caridi A; Curcio E; Drioli E
    J Pharm Sci; 2009 Dec; 98(12):4902-13. PubMed ID: 19655372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of crystal habit on the dissolution behaviour of simvastatin crystals and its relationship to crystallization solvent properties.
    Bukovec P; Benkic P; Smrkolj M; Vrecer F
    Pharmazie; 2016 May; 71(5):263-8. PubMed ID: 27348970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro and In Vivo Characterization of Drug Nanoparticles Prepared Using PureNano™ Continuous Crystallizer to Improve the Bioavailability of Poorly Water Soluble Drugs.
    Tahara K; Nishikawa M; Matsui K; Hisazumi K; Onodera R; Tozuka Y; Takeuchi H
    Pharm Res; 2016 Sep; 33(9):2259-68. PubMed ID: 27301372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid antisolvent crystallization of pharmaceutical compounds: current status and future perspectives.
    Kumar R; Thakur AK; Banerjee N; Kumar A; Gaurav GK; Arya RK
    Drug Deliv Transl Res; 2023 Feb; 13(2):400-418. PubMed ID: 35953765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing crystalline properties of a cardiovascular active pharmaceutical ingredient using a process analytical technology based crystallization feedback control strategy.
    Saleemi AN; Steele G; Pedge NI; Freeman A; Nagy ZK
    Int J Pharm; 2012 Jul; 430(1-2):56-64. PubMed ID: 22449455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of long-acting injectable suspensions by continuous antisolvent crystallization: An integrated bottom-up process.
    Nandi S; Padrela L; Tajber L; Collas A
    Int J Pharm; 2023 Dec; 648():123550. PubMed ID: 37890647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A flow-free droplet-based device for high throughput polymorphic crystallization.
    Yang SM; Zhang D; Chen W; Chen SC
    Lab Chip; 2015 Jun; 15(12):2680-7. PubMed ID: 25994475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.